Women screened for ovarian cancer do not have a reduced risk of death compared with women who receive their usual care, a clinical trial of nearly 80,000 women has found. The intervention group underwent a six-year screening process (including ultrasounds for four years), while the other group received their usual care. The intervention group was subject to more invasive medical procedures and associated harms as a result of being screened.
Read more at JAMA
Academic rigor, journalistic flair
Want to write?
Write an article and join a growing community of more than 183,000 academics and researchers from 4,949 institutions.